Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...

Nvidia's positions in these companies were relatively small at the end of the third quarter of 2025, but the chipmaker has spent recent years building a portfolio of AI‑related investments across ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. If you are trying to figure out whether Recursion Pharmaceuticals is ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

The co-founders of startup Ricursive Intelligence seemed destined to be co-founders. Anna Goldie, CEO, and Azalia Mirhoseini, CTO, are so well-known in the AI community that they were among those AI ...

VectorCertain Analyzed 3,434 OpenClaw Pull Requests Using Multi-Model Consensus, Identified Systemic Governance Failures, and Offered Creator Peter Steinberger a No-Cost SecureAgent License. He Joined ...

AI投毒产业链的猖獗，本质上是人类旧有的流量投机思维在AI新大陆上的一次“赛博圈地”与暴力掠夺。从批量制造垃圾软文到复杂的代码级指令注入，投毒者试图用噪音淹没真相。然而，正如科技史上的每一次技术博弈，试图通过欺骗算法收割流量的行为，最终必然会被系统进 ...

The pharmaceutical market, worth $1.7 trillion, offers stable long-term investment opportunities. Top pharma stocks like AbbVie and Pfizer are poised for growth despite patent challenges. Invest in ...